The Trump administration has enacted a temporary halt on communications from federal health agencies, including the CDC, NIH, and FDA, until February 1. This pause impacts regulations, guidance, and press releases, requiring approval from political appointees. Though transitions typically involve a review process, former officials noted that this freeze is unusually extended. The memo highlights a shift in control over public health communications and has raised concerns among staff who stress the importance of timely updates during health crises.
The Trump administration has ordered a freeze on federal health agency communications, effectively pausing regulations and announcements until approved by political appointees.
An 'immediate pause' on agency communications was communicated via memo, affecting vital health entities like the CDC, NIH, and FDA until February 1.
Former HHS officials noted that while it's typical for new administrations to reassess communications, the process usually operates more smoothly by inauguration day.
The pause applies to a range of communications, including guidance and scientific publications, reflecting a significant shift in federal health information dissemination.
Collection
[
|
...
]